An accurate and sensitive assay of [14C]octanoate oxidation and its application on tissue homogenates and fibroblasts.
A procedure was developed to assay [14C]octanoate oxidation from the production of both 14CO2 and 14C-labeled acid-soluble products. Octanoic acid and its CoA and carnitine esters were eliminated from the acid-soluble products by alkaline hydrolysis of the esters and acidification and binding of the acid to Lipidex 1000. The method was evaluated with homogenates of various rat tissues and human muscles and with human fibroblasts. 14CO2 production was variable and comprised less than 3% of the total oxidation products with homogenates and 26 +/- 19% with fibroblasts. As compared to palmitate, oxidation rates of octanoate were higher in rat liver and heart homogenates, of the same magnitude in muscle homogenates, but lower in fibroblasts. The proportion of antimycin-insensitive oxidation was much lower with octanoate than with palmitate. Using the assay a case of medium-chain acyl-CoA dehydrogenase deficiency could be indicated.
Veerkamp
J H
JH
van Moerkerk
H T
HT
Bakkeren
J A
JA
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000968:Antimycin A / Q000031:analogs & derivatives / Q000494:pharmacology; D002210:Caprylates / Q000378:metabolism*; D002245:Carbon Dioxide / Q000378:metabolism; D002331:Carnitine / Q000378:metabolism; D002648:Child; D003065:Coenzyme A / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis; D008875:Middle Aged; D009132:Muscles / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010084:Oxidation-Reduction; D019308:Palmitic Acid; D010169:Palmitic Acids / Q000378:metabolism; D051381:Rats
D002210:Caprylates; D010169:Palmitic Acids; C032456:antimycin; D002245:Carbon Dioxide; D019308:Palmitic Acid; D000968:Antimycin A; C031492:octanoic acid; D002331:Carnitine; D003065:Coenzyme A